Tijana Milinic,Kathleen J Ramos
Tijana Milinic
Exploring the Link Between Job Mobility, Health Insurance, and Health Related Financial Outcomes in People with Cystic Fibrosis [0.03%]
探索就业流动性、健康保险和囊性纤维化患者相关的财务结果之间的联系
Ryan C Perkins,Laura F Garabedian,Gregory S Sawicki
Ryan C Perkins
COPD and Inhaled Treatment Effects on Mortality in Lung Cancer Patients [0.03%]
慢性阻塞性肺疾病和吸入治疗对肺癌患者的影响
Jinwoo Lee,Jiyu Sun,Hyun Woo Lee
Jinwoo Lee
Introduction: In lung cancer patients, the impact of COPD diagnosis and subsequent management on mortality remains uncertain, as evidence supporting the efficacy of inhaled therapies in improving clinical outcomes in this...
Addressing Pediatric Asthma Disparities through RI-AIR's Community Approach: A Randomized Trial [0.03%]
RI-AIR社区方法解决儿科哮喘差异的随机试验：以社区为基础的方法应对儿童哮喘的不平等现象
Elizabeth L McQuaid,David Barker,Elizabeth S Chen et al.
Elizabeth L McQuaid et al.
Rationale: Clustering of social and environmental risks in low-income neighborhoods is a key factor in racial and ethnic asthma disparities. Integrating school and in-home programs, with treatment tailored to disease risk...
A Multidisciplinary Survey Comparing Academic and Community Critical Care Clinicians' ARDS Practice and the COVID-19 Pandemic [0.03%]
一项跨学科调查：比较学术界和社区重症监护医师的ARDS实践以及COVID-19大流行的影响
Diane Masket,Carey C Thomson,Andre Carlos Kajdacsy-Balla Amaral et al.
Diane Masket et al.
Rationale: Barriers to recognizing and treating acute respiratory distress syndrome (ARDS) exist. Prior studies have not investigated whether these barriers differ between academic and community settings, nor whether ther...
Kristina Gaietto,Molin Yue,Yueh Ying Han et al.
Kristina Gaietto et al.
Background and objectives: Exposure to violence has been associated asthma and worse asthma outcomes in youth, but no study has tested for an association between exposure to violence and specific asthma endotypes includin...
Harold J Farber
Harold J Farber
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in 6 to 11-Year-Olds with Cystic Fibrosis [0.03%]
用于6至11岁囊性纤维化患者的Elexacaftor/Tezacaftor/Ivacaftor疗效研究
Jessica E Pittman,Sarah Morgan,Morgan McCreary et al.
Jessica E Pittman et al.
Background: Elexacaftor/tezacaftor/ivacaftor (ETI) provided substantial health benefits to children with cystic fibrosis (CF) in clinical trials; there is less information about its effectiveness in a "real world" setting. Methods: The pedi...
Diabetes Mellitus and Lung Cancer Screening Outcomes in the National Lung Screening Trial [0.03%]
全国肺癌筛查试验中糖尿病对肺癌筛查结果的影响
Robert P Young,Ralph C Ward,Raewyn J Scott et al.
Robert P Young et al.
Background: Current eligibility criteria for lung cancer (LC) screening are derived from randomized controlled trials and largely based on age and smoking history. However, the individualised benefits of screening are hig...